Quantcast

Latest Pulmonary embolism Stories

2014-09-10 23:01:31

The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered life-threatening internal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or other serious injuries allegedly due to their use of the blood-thinning medication. New York, New York (PRWEB) September 10, 2014 A California woman has filed a new Xarelto lawsuit (http://www.xareltolawsuitcenter.com) that alleges uncontrollable hemorrhaging caused by the blood thinner nearly ended her life, Bernstein...

2014-09-10 08:29:40

Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and intellectual property rights relating to Arixtra® (fondaparinux sodium) Injection and the authorized generic (AG) of Arixtra from Aspen Global Incorporated. Arixtra...

2014-09-02 23:01:40

The Firm is evaluating Xarelto lawsuits on behalf of patients who suffered uncontrollable internal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death, allegedly due to their use of the blood thinner. New York, NY (PRWEB) September 02, 2014 The use of Xarelto (known generically as rivaroxaban) and other new blood thinners is growing at a rapid pace, even as Xarelto lawsuits (http://www.xareltolawsuitcenter.com) continue to mount in courts around the U.S., Bernstein...

2014-09-02 08:30:31

Patients at higher risk of kidney problems due to existing diabetes were also evaluated for the effects of warfarin on kidney function RIDGEFIELD, Conn., Sept. 2, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a new post-hoc sub-analysis of the pivotal phase III RE-LY® trial assessing renal function change in patients with non-valvular atrial fibrillation (NVAF) treated with Pradaxa® (dabigatran etexilate mesylate) compared to warfarin. The...

Aspirin May Reduce The Risk Of Blood Clots Reoccurring
2014-08-27 03:05:36

American Heart Association Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins, according to new research in the American Heart Association journal Circulation. In a combined analysis of two similar independent studies, 1,224 patients who received 100 mg of aspirin a day to treat blood clots were monitored for at least two years. In the International Collaboration of Aspirin Trials for...

2014-08-25 23:02:39

The Firm is evaluating testosterone lawsuits on behalf of men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, and other cardiovascular injuries, allegedly due to their use of prescription low testosterone therapies. New York, New York (PRWEB) August 25, 2014 Testosterone treatment lawsuits (http://www.injurybeacon.com/testosterone-androgel/) continue to move forward in a multidistrict litigation now underway in U.S. District Court, Northern District of...

2014-08-06 23:11:18

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. New York, NY (PRWEB) August 06, 2014 The birth control resource center at DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of new information on the site. A recent report shows the maker of the drugs has settled approximately 8,900 cases alleging they caused side effects*. DrugNews is a free online resource...

2014-07-30 23:01:48

The Firm is investigating Xarelto lawsuits on behalf of individuals who allegedly suffered uncontrollable bleeding, strokes, deep vein thrombosis, or pulmonary embolism due to the blood thinner. New York, New York (PRWEB) July 30, 2014 The family of a Vermont man who died from uncontrollable brain bleeding has filed a Xarelto lawsuit (http://www.xareltolawsuitcenter.com/ ) alleging his death was caused by the blood thinner, Bernstein Liebhard LLP reports. According to the complaint, which...

2014-07-30 12:30:01

Growth Will Be Driven Primarily By Adoption of Devices to Treat Stroke and Venous Thromboembolism, According to Findings from Decision Resources Group BURLINGTON, Mass., July 30, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years. This will be primarily as a result of increasing uptake of neurovascular embolectomy devices, designed for treating stroke patients, as well as...

2014-07-23 23:13:00

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) July 23, 2014 The birth control resource center at DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of new information on the site. A federal panel recently released updated records showing more than 8,500 cases still pending alleging side effects from the drugs*. DrugNews is a free online...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'